(Circulation. 2000;101:e91.)
© 2000 American Heart Association, Inc.
Circulation Electronic Pages |
Professor of Medicine The George Washington University, Washington, DC
| Introduction |
|---|
I read with interest the article on long-term follow-up after percutaneous mitral valvuloplasty with the Inoue balloon catheter by Hernandez et al.1 They reported a restenosis rate of 39% at 7 years.
My colleagues from China and I recently reported our experience with the same technique in a follow-up study up to 11 years in the first 202 patients2 among the original 4832 patients treated in China.3 The restenosis rate was 8%, which is very respectable and actually better than that after surgical closed commissurotomy (25% to 28%).2 Why the restenosis rate in the Chinese patients is much lower than that in the Spanish patients is unclear.
Our experience as well as a series of recent reports of excellent long-term results have strengthened the previous conclusion that percutaneous mitral valvuloplasty using the Inoue balloon technique should be the procedure of first choice in most patients with mitral stenosis worldwide.4
| References |
|---|
2. Chen C-R, Cheng TO, Chen J-Y, Huang Y-G, Huang T, Zhang B. Long-term results of percutaneous balloon mitral valvuloplasty for mitral stenosis: a follow-up study to 11 years in 202 patients. Cathet Cardiovasc Diagn. 1998;43:132139.[Medline] [Order article via Infotrieve]
3. Chen C, Cheng TO, for the Multicenter Study Group. Percutaneous balloon mitral valvuloplasty using Inoue technique: a multicenter study of 4832 patients in China. Am Heart J. 1995;129:11971204.[Medline] [Order article via Infotrieve]
4. Cheng TO, Holmes DR Jr. Percutaneous balloon mitral valvuloplasty by the Inoue balloon technique: the procedure of choice for treatment of mitral stenosis. Am J Cardiol. 1998;81:624628.[Medline] [Order article via Infotrieve]
Hospital Universitario San Carlos, Madrid, Spain
| Introduction |
|---|
We believe that this difference is more apparent that real. Our
restenosis rate after a mean follow-up of 39±23 months was
10%, rather similar to that reported by them (8% after 3.7±2.1
years). A different methodology may account for these differences: (1)
Our analysis took
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |